EGFR kinase inhibitor 7

SKU: orb2663652

Description

EGFRkinase inhibitor 7 (compound 18i) is an EGFR inhibitor with an IC50 of 42.3 nM, exhibiting anticancer properties. This compound demonstrates significant in vitro cytotoxicity and capacity to induce apoptosis. Furthermore, EGFRkinase inhibitor 7 displays anti-proliferative activity against human colon cancer cell line HCT116 and human non-small cell lung cancer cell line A549, with IC50 values of 4.82 µM and 1.43 µM, respectively.

Research Area

,Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis|||JAK/STAT signaling

Key Properties

• MW: 653.45
• Purity: 98.00%
• Formula: C₂₈H₂₆Cl₂FN₃O₃SSe

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only